• Mashup Score: 16

    I’m fundraising for the NYP SPORE Fund at NewYork-Presbyterian.

    Tweet Tweets with this article
    • In just a few weeks I'll be running the NYC marathon to raise funds for prostate cancer research! Every dollar goes to support community outreach, clinical trials, and translational research: https://t.co/LrDwnKCxPk

  • Mashup Score: 3

    Team:Anderson AklyLuigi MarchionniTimothy McClureDanielle MurtaghHimanshu NagarAndrea SbonerPankaj SharmaWhile we train and run the 2022 NYC Marathon (https://www.nyrr.org/tcsnycmarathon), we would like to invite you to contribute to our fundraising campaign for men’s health awareness and prostate cancer research.Every dollar raised will go directly to men’s health awareness and prostate cancer…

    Tweet Tweets with this article
    • Donate here: https://t.co/0WHEAezK3h @TimMcClureMD @asbonerw @marchionniLab https://t.co/Uvk5urRwLR

    • RT @HimanshuNagarMD: Donate here: https://t.co/0WHEAezK3h @TimMcClureMD @asbonerw @marchionniLab https://t.co/Uvk5urRwLR

  • Mashup Score: 1

    Purpose Molecular characterization of prostate cancer, including The Cancer Genome Atlas, has revealed distinct subtypes with underlying genomic alterations. One of these core subtypes, SPOP (speckle-type POZ protein) mutant prostate cancer, has previously only been identifiable via DNA sequencing, which has made the impact on prognosis and routinely used risk stratification parameters unclear….

    Tweet Tweets with this article
    • 8/ Next, we developed machine-learning classifiers to predict subtype and early/late status from transcriptional data, using 4 categories: ERG or SPOP (early), and PTEN or CHD1 (late), in an approach we’ve used before https://t.co/OBR84UTVAb. https://t.co/k3oenm9nlL